Management of Obesity as a Chronic Disease: Nonpharmacologic, Pharmacologic, and Surgical Options
Year: 2002
Type: review
Abstract: The successful management of obesity requires a long-term approach that is tailored to an individual's lifestyle and needs. Initial treatment should focus on lifestyle modifications-dietary interventions and increased physical activity-with behavioral modification strategies used adjunctively. Several antiobesity drugs are approved by the Food and Drug Administration for use in obese patients, as well as in overweight individuals with at least one obesity-related comorbidity. Most are approved only for short-term weight loss, but sibutramine and orlistat are approved for long-term weight loss and maintenance. In addition to weight reduction, in clinical trials these drugs provided beneficial actions on several cardiovascular risk factors. Several other drugs currently approved for other uses show promise in their ability to cause weight loss. Surgical options should be reserved for severely obese patients with significant medical comorbidities or physical conditions.
Source: Obesity Research
DOI: 10.1038/oby.2002.204
Author: Ken Fujioka
Institutions: Scripps Health, Scripps Clinic
Language: English
Subfield: Pharmacology (medical)
Field: Medicine
Domain: Health Sciences
Keywords: obesity treatment, obesity as chronic disease, lifestyle modification, dietary intervention, physical activity, behavior change, anti-obesity drugs, sibutramine, orlistat, weight loss maintenance, cardiovascular risk factors, bariatric surgery, morbid obesity, obesity-related comorbidities
Open Access status: bronze
OpenAlex ID: W2087880294
